Evidence map›Paper›PMID 26343579›Full record

ArticleCell2015

Pathogen Cell-to-Cell Variability Drives Heterogeneity in Host Immune Responses.

Roi Avraham, Nathan Haseley, Douglas Brown, Cristina Penaranda, Humberto B Jijon, John J Trombetta, Rahul Satija, Alex K Shalek, Ramnik J Xavier, Aviv Regev and 1 more

Erratum issuedAbstract read
In one paragraph

Article in Cell, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 175 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. bioRxiv : the preprint server for biology · 2026
    Article
  15. Article
  16. Article
  17. Review
  18. Review
  19. Article
  20. Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Roi AvrahamBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Nathan HaseleyBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Health, Sciences, and Technology, Massachusetts Institute of Technology, Boston, MA 02139, USA.
Douglas BrownBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Cristina PenarandaDepartment of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Humberto B JijonCenter for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Division of Gastroenterology, Department of Medicine, University of Calgary, Calgary, AB T2N 1N4, Canada.
John J TrombettaBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Rahul SatijaBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Alex K ShalekBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA.
Ramnik J XavierBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Gastrointestinal Unit, Center for the Study of Inflammatory Bowel Disease, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA.
Aviv RegevBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Howard Hughes Medical Institute, Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139, USA.
Deborah T HungBroad Institute of MIT and Harvard, Cambridge, MA 02142, USA; Department of Molecular Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Center for Computational and Integrative Biology, Massachusetts General Hospital, Boston, MA 02114, USA; Department of Microbiology and Immunobiology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: hung@molbio.mgh.harvard.edu.

Funding

Pilot & Feasibility ProgramP30DK043351 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI Ramnik J Xavier · 1991 to 2026
$35.3M
Genetic and Pathway Analysis CoreU19AI109725 · NIAID · WASHINGTON UNIVERSITY · PI VIRGIN, HERBERT W · 2014 to 2018
$32.7M
Training Program in Bioinformatics and Integrative GenomicsT32HG002295 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI Peter J Park · 2001 to 2026
$15.8M
Center for Cell CircuitsP50HG006193 · NHGRI · BROAD INSTITUTE, INC. · PI REGEV, AVIV · 2011 to 2015
$15.6M
The chromatin regulatory circuitry of bivalent domainsF32HD075541 · NICHD · BROAD INSTITUTE, INC. · PI SATIJA, RAHUL · 2013 to 2014
$99k
NHGRI NIH HHS HG002295NHGRI NIH HHS P50 HG006193NHGRI NIH HHS P50 HG006193)NHGRI NIH HHS T32 HG002295NIAID NIH HHS U19 AI109725NIAID NIH HHS U19AI109725NICHD NIH HHS F32 HD075541NICHD NIH HHS F32 HD075541-02NIDDK NIH HHS DK043351NIDDK NIH HHS P30 DK043351
6 · The paper itself

Abstract

Encounters between immune cells and invading bacteria ultimately determine the course of infection. These interactions are usually measured in populations of cells, masking cell-to-cell variation that may be important for infection outcome. To characterize the gene expression variation that underlies distinct infection outcomes and monitor infection phenotypes, we developed an experimental system that combines single-cell RNA-seq with fluorescent markers. Probing the responses of individual macrophages to invading Salmonella, we find that variation between individual infected host cells is determined by the heterogeneous activity of bacterial factors in individual infecting bacteria. We illustrate how variable PhoPQ activity in the population of invading bacteria drives variable host type I IFN responses by modifying LPS in a subset of bacteria. This work demonstrates a causative link between host and bacterial variability, with cell-to-cell variation between different bacteria being sufficient to drive radically different host immune responses. This co-variation has implications for host-pathogen dynamics in vivo.

Indexed as

Host-Pathogen InteractionsAnimalsInterferon Type ILipopolysaccharidesMacrophagesMiceMice, Inbred C57BLSalmonella InfectionsSalmonella typhimuriumSpecific Pathogen-Free OrganismsInterferon Type ILipopolysaccharides

Identifiers

PMID26343579
PMCPMC4578813

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.